In a different approach, administration of an ASO inhibitor of miR-129-5p to an ALS animal model, SOD1 (G93A) mice, resulted in a significant increase in survival and improved the neuromuscular phenotype in treated mice (Loffreda et al., 2020). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.